secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aprea Therapeutics, Inc. (APRE)
CIK:        0001781983
Form:       8-K
Filed at:   2024-11-08T23:59:59+00:00
Accession:  0001104659-24-115911
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aprea Therapeutics enters ATM equity offering agreement for up to $3.0M with H.C. Wainwright
--------------------------------------------------------------------------------

- Aprea entered into an at-the-market offering agreement with H.C. Wainwright to sell up to $3.0M of common stock.
- HCW will serve as sales agent and receive a 3.0% commission on gross proceeds from sales.
- Net proceeds will fund general corporate purposes, including preclinical studies and clinical trials.
- The company is not obligated to sell any shares under the agreement; sales may occur from time to time.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1781983/000110465924115911/0001104659-24-115911-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1781983/000110465924115911/tm2427608d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-115911

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer